Two IDWeek 2026 studies link influenza vaccination to fewer ICU admissions in older adults and fewer emergency visits in children.
|Articles|February 28, 2022
Daily OTC Pearl: Vicks Dayquil
Author(s)Saro Arakelians, PharmD
Dayquil offers relief for the symptoms of cold and flu.
Advertisement
OTC/Lifestyle Pearl of the Day: Vicks Dayquil
Indication: Dayquil is an OTC medication that treats daytime symptoms of cold and flu, which can include nasal congestion, cough, headache, minor aches and pains, fever and sore throat.
Insight:
- Dayquil can be taken every 4 hours. Do not exceed 4 doses within 24 hours.
- Dayquil Cough can be taken every 6-8 hours.
- Dayquil treats cold and flu symptoms for approximately 4 hours. Dayquil Cough provides up to 8 hours of cough relief.
- If pregnant or breast-feeding, check with a health professional before taking Dayquil.
Sources:
Advertisement
Related to this article
The project maps how flu and HIV proteins enter cells, with the aim of developing longer-lasting vaccines.
Two Kidney Week 2026 abstracts show a dose-response link between cardiovascular-kidney-metabolic syndrome (CKM) stage and chronic kidney disease (CKD), while primary care clinicians cite evidence and workflow barriers.
In more than 262,000 UK Biobank participants, a 5-marker cardiometabolic score was linked to graded risk at each step toward CKM multimorbidity.
The approval offers a once-weekly basal insulin treatment option for patients, reducing the frequency of injections.
Early data suggest the 7 PCV20-added serotypes are causing a smaller share of invasive pneumococcal disease in children younger than 2 years.
In pooled CORALreef data, patients with eGFR below 60 had a 65.9% placebo-adjusted LDL-C reduction at week 24, with safety comparable to placebo.
Pharmacy Times will feature experts on kidney function assessment, IgG4-related disease, emerging CKD therapies, and gaps in cardiorenal care.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Flu Vaccination Linked to Fewer Severe Outcomes in Older Adults, Fewer ED Visits in Children
2
Combined Cardiometabolic Biomarker Burden Tracks CKM Progression
3
FDA Approves Bepirovirsen, First ASO for Chronic Hepatitis B
4
CKM Syndrome Stage Linked to CKD Odds, But Primary Care Hurdles Remain
5